Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2019-08-02 Regulatory Filings
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated August 2, 2019. It explicitly states it is making a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 regarding 'Total Voting Rights'. This type of mandatory, short regulatory update, often distributed via the London Stock Exchange's RNS system, fits the description of a general regulatory announcement that doesn't fit a more specific category like earnings or management changes. While it is a regulatory filing, the presence of the RNS Number and the nature of the content (Total Voting Rights update) strongly suggests classification as RNS, which serves as the general regulatory filing category.
2019-08-02 English
Half Year Trading Update
Earnings Release Classification · 99% confidence The document is explicitly marked with an 'RNS Number' and contains the header 'RNS Number : 7500F' and concludes with information about RNS, the news service of the London Stock Exchange. The content itself is a 'Half Year Trading Update' for the six months ended 30 June 2019, providing key financial highlights (revenue, profit expectations, cash flow, leverage) and announcing a new credit facility. This is a pre-close update, not the full Interim Report (IR) or Annual Report (10-K). Since it is a formal, immediate announcement disseminated via the regulatory news service (RNS), and it provides key financial highlights before the full report, it fits best under the Earnings Release (ER) category, which covers initial announcements of periodical financial results (key highlights only). However, given the strong RNS identification and the nature of the announcement (a trading update/pre-close), it also strongly aligns with the general Regulatory Filings (RNS) category, which serves as a fallback for specific announcements. Since 'ER' specifically covers 'Initial announcement of quarterly/periodical financial results (key highlights only)', and this is a 'Half Year Trading Update' with key figures, ER is the most precise fit among the specific financial categories. If it were merely announcing the release date of the full report, RPA would apply, but this document contains the actual results summary. H1 2019
2019-07-17 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is explicitly marked with an 'RNS Number' and contains the header 'RNS Number : 0539E'. It announces the 'Total Voting Rights' as required by the FCA's Disclosure and Transparency Rule 5.6.1, providing the total number of shares and voting rights as of a specific date (28 June 2019). This type of mandatory, short regulatory update, distributed via the London Stock Exchange's news service (RNS), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). Given the explicit RNS identification and the nature of the disclosure, RNS is the most appropriate code.
2019-07-01 English
Block Listing Six Monthly Return
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with an 'RNS Number' and contains information about the London Stock Exchange's news service. The content details a 'Block Listing Six Monthly Return' concerning share option plans and the balance of unallotted securities over a specific six-month period (December 28, 2018, to June 28, 2019). This type of routine regulatory update regarding share capital structure and options, distributed via the RNS system, fits best under the general 'Regulatory Filings' category, as there is no specific code for a 'Block Listing Return'. It is not an earnings release, annual report, or management disclosure, but a mandatory regulatory notification.
2019-07-01 English
Directorate Change
Board/Management Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 9314D) on 01 July 2019. The core content explicitly states: "Directorate Change" and announces that "John Dawson, Non-Executive Director... has decided to step down from the Company's Board". This directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific content is about management change, making MANG the most precise classification.
2019-07-01 English
Group of companies' accounts made up to 2018-12-31
Regulatory Filings
2019-06-06 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.